MOLNLYCKE HEALTH CARE - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,966,179 | 2,188,838 | 2,436,396 | 2,876,408 | 3,578,335 | 3,599,425 | 3,668,556 | 4,747,840 |
| Profit before tax | 67,034 | 178,859 | 142,196 | 62,079 | 129,456 | 189,758 | 520,100 | 329,317 |
| Net profit | 52,175 | 150,215 | 119,598 | 53,586 | 110,648 | 157,320 | 439,051 | 273,283 |
| Equity | 361,839 | 512,054 | 631,652 | 685,238 | 795,886 | 953,206 | 1,392,257 | 1,258,109 |
| Liabilities | 464,053 | 308,656 | 244,452 | 338,468 | 396,344 | 217,052 | 220,106 | 200,682 |
| Non-current assets | 4,228 | 11,146 | 7,327 | 3,600 | 8,548 | 6,548 | 3,532 | 6,666 |
| Current assets | 857,311 | 822,935 | 871,242 | 1,037,811 | 1,191,377 | 1,179,976 | 1,631,590 | 1,469,477 |
| Total assets | 861,539 | 834,081 | 878,569 | 1,041,411 | 1,199,925 | 1,186,524 | 1,635,122 | 1,476,143 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 600,877 | 735,231 | 1,031,410 |
| Social insurance contributions | - | - | - | - | - | 71,626 | 64,138 | 63,866 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.2% | +11.3% | +11.3% | +18.1% | +24.4% | +0.6% | +1.9% | +29.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.1% | 18.0% | 13.6% | 5.1% | 9.2% | 13.3% | 26.9% | 18.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.4% | 29.3% | 18.9% | 7.8% | 13.9% | 16.5% | 31.5% | 21.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.7% | 6.9% | 4.9% | 1.9% | 3.1% | 4.4% | 12.0% | 5.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.4% | 8.2% | 5.8% | 2.2% | 3.6% | 5.3% | 14.2% | 6.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 0.6 | 0.4 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 341,944 | 437,768 | 562,250 | 460,225 | 536,748 | 514,204 | 657,059 | 780,471 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MOLNLYCKE HEALTH CARE - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-16 | 2025-06-04 | 4357.61 |
| 2025-03-04 | 2025-03-05 | 4.43 |
| 2025-02-27 | 2025-03-02 | 4.43 |
| 2024-02-22 | 2024-02-22 | 21.09 |
| 2024-02-19 | 2024-02-21 | 59.90 |
| 2023-04-18 | 2023-04-18 | 17.40 |
| 2022-07-18 | 2022-07-26 | 4359.54 |
MOLNLYCKE HEALTH CARE - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MOLNLYCKE HEALTH CARE, UAB (code 303199941) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €4.75M, up 29.4% year on year and 31.9% over two years. Net profit reached €273.3K, after €439.1K in 2024 and €157.3K in 2023, showing a strong but uneven profit trajectory. The profit margin was 5.8% in 2025, compared with 12.0% in 2024 and 4.4% in 2023. The balance sheet remained conservative, with total assets of €1.48M, equity of €1.26M and liabilities of €200.7K at the end of 2025. Key ratios indicate solid efficiency and low leverage: ROE was 21.7%, ROA 18.5%, debt-to-equity 0.16 and asset turnover 3.22x. Based on the available staff data, revenue per employee was €791.3K and profit per employee €45.5K in 2025.